Whalegun
Home

Amneal Pharmaceuticals AMRX spent $190K on lobbying in Q1 2026 · Health Issues

Trade details

Type
Lobbying report
Amount
$190,000
Quarter
Q1 2026
Stock
Amneal Pharmaceuticals AMRX
Client
Amneal Pharmaceuticals
Reported
26/04/20

Down 44.1% from last quarter

What else happened in Amneal Pharmaceuticals around then

Filed or reported within 30 days of the trade day · 03/01~04/30

Amneal Pharmaceuticals's other lobbying reports